Platform|API|Archive|Contact

Humanexa SignalsPharmaceutical Intelligence

FDA
EMA
MHRA
PMDA
Health Canada

Phase I
Phase II
Phase III
Readouts
Enrollment Signals

Pipeline Tracking
Company Moves
Asset Intelligence
Landscape Reports

Pricing
Access
Commercial
Launch Tracking

Licensing
Acquisitions
Partnerships
Capital Raises

Strategy Catalysts Pricing

Humanexa Signals

Data-driven pharmaceutical intelligence for biotech investors, pharma operators, consultants, and intelligence teams.

Powered by Humanexa

Categories

Regulatory
Clinical
Competitive
Markets
M&A Watch
Strategy
Catalyst Tracker

Company

Pricing
Partner with us
Subscribe
Contact
Privacy

Subscribe to Humanexa Signals

Weekly intelligence for pharma decision-makers.

No paywall. No spam. Unsubscribe anytime.

© 2026 Humanexa Signals. All rights reserved.

Intelligence powered by the Humanexa engine.

Therapeutic Area

Veterinary Medicine

Therapeutic area intelligence for Veterinary Medicine with 5 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals: 5
Catalysts: 0
Companies: 1

Companies

veterinary pharmaceutical companies →

Assets

Recent signals(5)

RegulatoryAugust 8, 2026

FDA Grants EUA for CLiK Extra to Combat New World Screwworm in Livestock

The FDA has issued an Emergency Use Authorization for CLiK Extra, a topical suspension for preventing New World screwworm infestations in livestock.

RegulatoryAugust 4, 2026

American Regent Issues Nationwide Recall of Adequan® Canine and I.M. Lots

American Regent, Inc. is recalling two lots of Adequan® Canine and two lots of Adequan® I.M. due to safety concerns.

RegulatoryJuly 16, 2026

FDA Grants EUA for Ivermectin Liquid to Prevent New World Screwworm in Horses

The FDA has issued an Emergency Use Authorization for Ivermectin Liquid for Horses to prevent New World screwworm infestations.

RegulatoryJuly 3, 2026

FDA Reports Increase in Accidental Overdoses of Apoquel Chewable in Dogs

The FDA has noted a rise in reports of accidental overdoses of Apoquel Chewable in dogs.

RegulatoryJune 22, 2026

FDA Grants EUA for Nitenpyram Tablets to Treat New World Screwworm in Pets

The FDA has issued an Emergency Use Authorization for Nitenpyram Tablets to treat New World screwworm infestations in dogs and cats.

Upcoming catalysts

No catalysts indexed for this entity yet.

Indications

No related entities indexed yet.

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.